VeriChip Corporation Receives $4.4 Million in Cash Proceeds Related to Sale of Its Former Xmark Subsidiary to The Stanley Works
22 7월 2009 - 9:30PM
Business Wire
VeriChip Corporation (NASDAQ:CHIP) (�VeriChip� or the
�Company�), a provider of radio frequency identification (RFID)
systems for healthcare and patient-related needs, announced today
that it has received $4.4 million in escrow proceeds related to the
July 2008 sale of its former Xmark Corporation subsidiary to The
Stanley Works.
As a result of the release of the escrow, the Company will
recognize its previously deferred gain of $4.4 million on its
financial statements for the quarter ended June 30, 2009, which
will be additive to its stockholders� equity.
Scott R. Silverman, Chairman of VeriChip, said, �As expected, we
have received the escrow funds related to the $48 million sale of
our former Xmark subsidiary. As a result, we believe that the
Company once again satisfies the stockholders� equity requirement
($2.5 million) applicable to continued listing on The Nasdaq
Capital Market. We expect to sustain compliance with that
requirement for the foreseeable future.�
The Company may host a conference call in the coming weeks to
discuss its future plans.
About VeriChip Corporation
VeriChip Corporation, headquartered in Delray Beach, Florida,
has developed the VeriMed� Health Link System for rapidly and
accurately identifying people who arrive in an emergency room and
are unable to communicate. This system uses the first
human-implantable passive RFID microchip, cleared for medical use
in October 2004 by the United States Food and Drug Administration.
To complement its healthcare division, VeriChip Corporation
established VeriGreen Energy Corporation in March 2009 to focus and
invest in the clean and alternative energy sector.
For more information on VeriChip, please call 1-800-970-2447, or
e-mail info@verichipcorp.com. Additional information can be found
online at www.verichipcorp.com.
Statements about VeriChip�s future expectations, its belief that
it satisfies the stockholders� equity requirement applicable to
continued listing on The Nasdaq Capital Market and its expectation
to sustain compliance with that requirement for the foreseeable
future, and all other statements in this press release other than
historical facts are �forward-looking statements� within the
meaning of Section 27A of the Securities Act of 1933, Section 21E
of the Securities Exchange Act of 1934, and as that term is defined
in the Private Litigation Reform Act of 1995. Such forward-looking
statements involve risks and uncertainties and are subject to
change at any time, and VeriChip�s actual results could differ
materially from expected results. Additional information about
these and other factors that could affect the Company�s business is
set forth in the Company�s various filings with the Securities and
Exchange Commission, including those set forth in the Company�s
10-K filed on February 12, 2009, under the caption �Risk Factors.�
The Company undertakes no obligation to update or release any
revisions to these forward-looking statements to reflect events or
circumstances after the date of this statement or to reflect the
occurrence of unanticipated events, except as required by law.
Verichip (MM) (NASDAQ:CHIP)
과거 데이터 주식 차트
부터 6월(6) 2024 으로 7월(7) 2024
Verichip (MM) (NASDAQ:CHIP)
과거 데이터 주식 차트
부터 7월(7) 2023 으로 7월(7) 2024
